NTH — Naturhouse Health SA Cashflow Statement
0.000.00%
Last trade - 00:00- €149.27m
- €137.24m
- €47.63m
Annual cashflow statement for Naturhouse Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 18.2 | 13.1 | 15.4 | 13.5 | 13.7 |
| Depreciation | |||||
| Non-Cash Items | -0.234 | 0.371 | 0.169 | -0.207 | -0.307 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.29 | -8.68 | 3.1 | -3.73 | -2.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 16.2 | 7.1 | 20.9 | 11.6 | 12.1 |
| Capital Expenditures | -0.05 | -0.964 | -0.57 | -0.338 | -0.472 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.22 | -4.25 | 0.111 | 1.2 | 0.052 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.27 | -5.22 | -0.459 | 0.862 | -0.42 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.27 | -17 | -7.7 | -16.1 | -19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.64 | -15.1 | 12.3 | -3.71 | -7.26 |